Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology.
Rangasamy SB, Jana M, Roy A, Corbett GT, Kundu M, Chandra S, Mondal S, Dasarathi S, Mufson EJ, Mishra RK, Luan CH, Bennett DA, Pahan K.
Rangasamy SB, et al. Among authors: kundu m.
J Clin Invest. 2018 Oct 1;128(10):4297-4312. doi: 10.1172/JCI96209. Epub 2018 Jul 10.
J Clin Invest. 2018.
PMID: 29990310
Free PMC article.